TỔN THƯƠNG THẬN CẤP Ở BỆNH NHÂN ĐƯỢC THỰC HIỆN OXY HÓA MÁU QUA MÀNG NGOÀI CƠ THỂ (ECMO)

Abstract

Objectives: Describe the characteristics of acute kidney injury and comment on treatment results in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: Retrospective study of medical records of patients undergoing ECMO technique from January 1, 2022 to June 30, 2023 at the intensive care center of Bach Mai hospital. Results: with 91 patients included in the study, the rate of AKI was 76.9%, and 54.9% of AKI patients were treated with RRT. The rates of AKI before ECMO and after ECMO were: 52.7% and 24.1%. ECMO is a risk factor for increasing the severity of AKI. Common causes in our research group are myocarditis and ARDS. Factors found to be related to AKI are as follows: Hyperlactatemia, SOFA and high APACHE II score, MAP, P/F, EF, presence of circulatory arrest before ECMO, ECMO mode, important bleeding, infection, platelets are transfused during ECMO. The overall mortality rate in the study group was 54.9%, the mortality rate in the ECMO patient group with AKI was 73.6% and the ECMO patient group without AKI was 32.0%. AKI is a factor that increases the risk of death in patients receiving ECMO treatment by 1.87 (95% CI: 1.23-2.83).